There are currently no known outstanding effects for the The Biocidal Products and Chemicals (Appointment of Authorities and Enforcement) Regulations 2013, Paragraph 11.
[F111. For the purposes of regulation 13 of these Regulations, essential use derogations granted by the Commission before [F2IP completion day] (under either Regulation 1062/2014 or its predecessor Regulation 1451/2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market) are deemed to have been granted by the Secretary of State subject to the same terms and conditions.]E+W+S
Textual Amendments
F1Sch. 2 para. 11 inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 1 para. 28(b); 2020 c. 1, Sch. 5 para. 1(1)
F2Words in Sch. 2 para. 11 substituted (1.11.2022) by The Chemicals (Health and Safety) Trade and Miscellaneous Amendments Regulations 2022 (S.I. 2022/1037), regs. 1(2), 13(4)
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
